Press Release FeedGet the RSS feed
Menu

GlobeNewswire

High Roller Technologies Diamond Sponsor of the NEXTPredict 2026 Conference

GlobeNewswire

Company’s new Chief Business Officer Flip Pidot will be one of the hosts of a key panel at NEXTPredict 2026

Prediction markets summit takes place October 22–23 at Hudson Yards in New York City

LAS VEGAS, Nevada, Oct. 19, 2026 -- High Roller Technologies, Inc. (“High Roller” or the “Company”) (NYSE: ROLR), an online gaming and prediction markets company, today announced that Chief Business Officer Flip Pidot will participate at NEXTPredict 2026, taking place October 22–23, 2026, at Hudson Yards in New York City. The Company’s prediction markets brand, ROLR™, is a Diamond level sponsor of the NEXTPredict 2026 conference.

Flip Pidot joins a panel focusing on one question: predict which party will hold the Senate after the midterms? This isn't political commentary - it's a high-conviction debate anchored on a single prediction-market contract. Each voice on stage takes a definitive position on the market and defends it with the data, the odds and the thesis behind the call. Recorded live as an episode of the Betting the Future podcast with Dalton Skach, it puts the smart money on the record, and on the line, before the results come in.

Conference Details

Event: NEXTPredict 2026
Dates: Thursday, October 22–Friday, October 23, 2026
Location: Hudson Yards, New York City

Panel: Flip Pidot, Chief Business Officer, High Roller Technologies
Topic: Who Takes the Senate? A Live Market Debate
Date and Time: October 23, 12:10 p.m. ET

Agenda and registration: Registration

NEXTPredict brings together prediction markets operators, financial institutions, investors, technology providers and regulatory experts to discuss the industry’s development. The conference agenda addresses market structure, institutional participation, technology, consumer adoption and the evolving regulatory environment.

The conference’s speaker lineup includes executives from DraftKings, Robinhood, Crypto.com, Kalshi and Polymarket, alongside representatives from major financial institutions and media organizations.

About High Roller Technologies, Inc.

High Roller Technologies, Inc. (NYSE: ROLR) is a publicly traded online gaming and prediction markets company, known for its innovative casino brands High Roller and Fruta, and its prediction markets brand, ROLR. The Company delivers cutting-edge real-money consumer facing products that are intuitive and user-friendly. With a diverse portfolio of over 6,000 premium online casino games from more than 90 leading game providers, High Roller Technologies offers an immersive and engaging gaming experience in the rapidly expanding multi-billion-dollar iGaming industry. As an award-winning operator, High Roller Technologies continues to redefine the future of market engagement through innovation, performance, and a commitment to excellence.

For more information, please visit the Company’s investor relations website and follow High Roller Technologies on X, Facebook, and LinkedIn.

Forward-Looking Statements

Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions, the commercial launch timing of the ROLR™ prediction markets platform. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the ability of the Company to successfully complete the closed beta on the anticipated timeline, risks related to platform stability, scalability and technical readiness, the regulatory environment applicable to prediction markets, the Company’s ability to attract and retain platform users, and general market and economic conditions and such factors as discussed throughout Part I, Item 1A. Risk Factors and Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations of our Annual Report on Form 10-K for the year ended December 31, 2025, Part I. Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations and Part II, Item 1A. Risk Factors, of our quarterly report on Form 10-Q for the quarter ended June 30, 2026 and in our other filings with the Securities and Exchange Commission. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Contact

Investor Relations
[email protected]

800-460-1039

  1. Aerospace & defenseGlobalstar, Inc.FCC Authorizes Globalstar’s Third-Generation C-3 System for Operations in the United StatesPurpose-built for direct-to-device connectivity, C-3 satellites are expected to launch beginning next year
  2. FinanceINLIF LIMITED Announces Pricing of $3.75 Million Registered Direct OfferingINLIF LIMITED (Nasdaq: INLF) (together with all its subsidiaries and consolidated entities, the "Company" or "INLIF"), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today announced that it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of an aggregate of 435,000 Class A Ordinary Shares, par value of US$0.0001 per share, of the Company (the “Ordinary Shares”), pre-funded warrants to purchase up to 1,908,750 Ordinary Shares (the “Pre-Funded Warrants”), Series A warrants to initially purchase up to 2,343,750 Ordinary Shares (the “Series A Warrants”), Series B warrants to initially purchase up to 2,343,750 units (the “Series B Warrants”, each unit consisting of one Ordinary Share, or one Pre-Funded Warrant in lieu thereof and one Series A Warrant ), and Series C warrants to purchase a number of Ordinary Shares to be determined in accordance with their terms (the “Series C Warrants” and, together with the Series A Warrants and the Series B Warrants, the “Ordinary Warrants”), in a registered direct offering (the “Offering”). Each Ordinary Share or Pre-Funded Warrant will be sold together with one accompanying Series A Warrant, one accompanying Series B Warrant and one accompanying Series C Warrant at a combined purchase price of US$1.60 per Ordinary Share and accompanying Ordinary Warrants, or US$1.5999 per Pre-Funded Warrant and accompanying Ordinary Warrants, which equals the combined purchase price per Ordinary Share and accompanying Ordinary Warrants minus US$0.0001, the exercise price of each Pre-Funded Warrant. The aggregate gross proceeds from the Offering are expected to be approximately US$3.75 million, prior to deducting placement agent fees, legal fees, administrative and other offering-related expenses.
  3. FinanceBioCardia Announces FDA Acceptance of De Novo Pre-Submission Package for Helix™ Catheter Marketing Clearance FDA Substantive Review and Meeting Expected this QuarterBioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the FDA has accepted its pre-submission package for marketing clearance of its Helix catheter (“Helix”) intended for therapeutic and diagnostic agent delivery.
  4. FinanceMoney, Rates, and Megawatts. The Three Questions Deciding the AI Buildout.Harmol Samra, Chief Executive Officer, Host Digital (NYSE American: HOST) letter to shareholders:
  5. Papa John's International, Inc. Class Action Reminder - Robbins LLP Encourages PZZA Investors to Contact the Firm for Information About Their RightsPapa John's faces allegations it misled investors regarding its business prospects in connection with its sales, dividend, and 2026 financial outlook.
  6. Fr8Tech Simplifies Capital Structure by Retiring Legacy Preferred Shares and Clearing 2023 WarrantsCompany exchanged all outstanding Series A4 preferred shares and 3,190,000 Series C preferred shares for rights to ordinary shares; legacy warrants from 2023 financing are fully cleared; simplified capital structure supports transition to a pure-play technology company